Leukemia - Defibrotide reduces procoagulant activity and increases fibrinolytic properties of endothelial cells Skip to main content Thank you for visiting nature.com.

Researchers from the University of Texas have determined the procoagulant activity of clinical cellular therapeutics (CCTs). CCTs include human mesenchymal stromal cells (MSC) and mononuclear ...

The procoagulant imbalance associated with chronic liver disease can be detected by measuring thrombin generation in plasma in the presence and absence of thrombomodulin. 18 An alternative method ...

We hypothesized that in this malignancy, procoagulant and inflammatory mediators contribute to the pathogenesis of such complications and warfarin may down regulate these levels. Methods: In a ...

Bevacizumab (BV), a monoclonal antibody against VEGF, has shown antitumor activity, but so far no biomarkers have been identified to predict outcome. The purpose of the present study was to ...

A 55-year-old man presents with a small-bowel perforation, and sepsis develops. Treatment with recombinant human activated protein C is recommended. Activated protein C inhibits the procoagulant st ...